Vimarsana
Biggest News Aggregation in the World

Page 5 - Visual Acuity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Visual Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Visual Acuity Today - Breaking & Trending Today

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System - Vimarsana News

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Vivani Medical, Inc. , an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic implants, announced today that its wholly-owned...

The Pikachu-SpongeBob Challenge: Can You Find the Hidden SpongeBob in this Optical Illusion? - Vimarsana News

The Pikachu-SpongeBob Challenge: Can You Find the Hidden SpongeBob in this Optical Illusion?

This optical illusion is challenging your visual acuity and problem-solving skills. Can you find SpongeBob in 13 seconds? If you can, you have a keen eye for detail and excellent problem-solving skills.

OCTA-based Assessment of Diabetic Macular Ischemia May Help Evaluate DR Progression - Vimarsana News

OCTA-based Assessment of Diabetic Macular Ischemia May Help Evaluate DR Progression

The findings could provide insight into incorporating both OCTA and artificial intelligence for early detection of DMI and better enhancing the management of diabetic retinopathy.

'Tunable' Lenses Offer New Way to Correct Presbyopia - Vimarsana News

'Tunable' Lenses Offer New Way to Correct Presbyopia

Adaptive liquid crystal lenses can be electrically tuned to any optical power, according to researchers.

Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity - Vimarsana News

Uncontrolled Wet AMD: Drug Switch Can Mute Disease Activity

Phase 3 data from the 2023 ARVO meeting showed treatment with the monoclonal antibody improved visual acuity in some patients.